Filgrastim Completed Phase 3 Trials for Stage IV Childhood Hodgkin Lymphoma / Childhood Lymphocyte-Depleted Classical Hodgkin Lymphoma / Childhood Nodular Sclerosis Classical Hodgkin Lymphoma / Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma / Stage I Childhood Hodgkin Lymphoma / Stage III Childhood Hodgkin Lymphoma / Stage II Childhood Hodgkin Lymphoma / Childhood Mixed Cellularity Classical Hodgkin Lymphoma / Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00025259Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease
NCT00278408Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
NCT00002835Combination Chemotherapy in Treating Patients With Lymphoma
NCT00052923Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma
NCT00003215Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma
NCT00003595Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma
NCT00012051Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
NCT00005589Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
NCT00002618Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma